NCDs, Part II: Evidence Development to Fulfill CED Requirements
Summary
Tune into the second episode in the Avalere Health Essential Voice podcast series focused on the how CMS and Medicare coverage decisions define patient access. In this segment, our experts continue the conversation around national coverage determinations (NCDs)that have coverage with evidence development (CED) requirements, how FDA and CMS’s evidence questions can be complimentary, and the ways in which manufacturer evidence generation plans can address those goals, using the NCD on monoclonal antibodies for Alzheimer's disease as an example.
On the Record: Health Plan and Provider Perspectives Video Series
Federal and state policymakers are actively shaping health coverage and access, and we’re here to explain exactly what these changes mean for plans and providers.
Watch the video series
Connect with the team directly
Services
From beginning to end, our team synergy
produces measurable results. Let's work together.
produces measurable results. Let's work together.
